ArticleFrontiers in immunology2025

Low-dose emapalumab treatment in refractory macrophage activation syndrome secondary to adult onset still's disease/systemic lupus erythematosus: insights from nine cases.

Jie Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.